WATERTOWN, Mass., Nov. 03, 2023 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of ...

Preliminary data on WTX-124 provide compelling early evidence of dose-dependent biomarker and antitumor activity in patients with advanced or metastatic solid tumors relapsed or refractory to standard ...

Cyanide SA, the studio behind Styx: Master of Shadows and Pro Cycling Manager, unveiled a new cinematic trailer for their upcoming title. Werewolf: The Apocalypse- Earthblood is based on the Werewolf: ...